Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus.
Zhaonan LiGuangyan SiDe-Chao JiaoXinwei HanWen Guang ZhangYahua LiXueliang ZhouJuanfang LiuJianjian ChenPublished in: BioMed research international (2020)
PVS combined with 125I particle chain implantation followed by TACE with As2O3 is safe and feasible for patients with PVTT. The long-term efficacy of this treatment needs to be further studied.